Portfolio

Engineering platform collagen technology to diagnose fibrosis and advance tissue regeneration science.

Innovating drug formulations to provide better treatments for global patient well-being.

Discovering autoimmune and cancer immunotherapies inspired by the microbiome.

Developing bioengineered heparin using genetically engineered microbes to create a reliable, animal-independent supply and address critical drug shortages.

The Bonneville Bio team is focused on identifying targets and bringing novel therapeutics to the clinic for treatment of various cancer indications.

Developing engineered myeloid cell therapies that harness macrophage invasiveness to infiltrate solid tumors and reverse immune suppression.

Developing a first-in-class, brain-penetrant microtubule stabilizer to preserve neuronal structure and address shared neurodegenerative pathologies.

Improving drug discovery success rates by putting a digital cell into every laboratory

We've simplified the operation of cardiac screening to the point that medical assistance and even at home patients can operate.

Helping frontline clinicians meet time-critical deadlines with point-of-care tracking and reminder systems.

Capturing the most comprehensive biomedical dataset for accelerating drug discovery.

Deploying novel polymer-controlled drug delivery devices to treat orthopedic and other surgical bone infections.

Pioneering noninvasive, point-of-care diagnostics to provide efficient and economical eosinophilic disease tracking for chronic rhinosinusitis patients.

Developing a first-in-class, oral immunotherapy that inhibits exosome biogenesis to prevent tumor-driven immune evasion and train the body to fight cancer.

Optimizing drug candidates using a novel drug discovery platform.

Revolutionizing Preclinical Vision Research with the Light-Responsive Human Eye

Developing the first wearable, real-time biofeedback device to change the paradigm of pelvic floor care.

Transforming the separation, purification, and characterization of bio nanoparticles with a new generation of environmentally-friendly and affordable instruments.

Engineering tissues to revolutionize biocomputation and regenerative medicine.

Building a predictive engine to determine the right treatment for every cancer.

Reimagining medicinal chemistry with lots of data and an absurd amount of biochemistry.

Pioneering biotechnology to make early cancer detection affordable and accessible to everyone, everywhere.

We are accelerating therapeutic development for rare diseases through patient-powered partnerships and drug discovery and repurposing.

Develop a point-of-care, non-invasive, easily accessible method for screening anemia.

Delivering AI-driven diagnostics to the palm of your hand.

Pioneering the battle against chronic kidney disease by exploring groundbreaking biochemical pathways and utilizing advanced computational techniques.

Detecting inflammation in eosinophilic diseases with leading diagnostics and therapies.

Working at the intersection of nature and technology to treat cancer and inflammation.

Operating system for drug development and biomarker discovery on a mission to accelerate precision therapeutics.

AI Enterprise Solutions for Image-Based Drug Discovery and Beyond.

Generating safe and effective alternatives to opioids for acute pain management.

Empowering therapeutic discovery through advanced peptide research and development.

Redox Reimagined: Reversing Disease

Our mission is to prevent blindness with the early detection of eye disease, and using the resulting proprietary data set to build a platform for healthcare data analytics.

Providing drug-free noninvasive therapies.

Pioneering single-dose regenerative gene therapies to reverse cellular drivers of osteoarthritis and degenerative disc disease.

To provide a functional cure for patients suffering from Type I & II Diabetes.

AI-powered clinical development to supercharge medical innovation.

Unlocking immune response to guide life changing therapies.

Transform recovery by developing novel, impactful regenerative medicines and gene therapies.

Improving outcomes for patients suffering from neurodegenerative disease with next-gen screening diagnostics